Logo image of ALMKS.PA

MAKING SCIENCE GROUP SA (ALMKS.PA) Stock Fundamental Analysis

EPA:ALMKS - Euronext Paris - Matif - ES0105463006 - Common Stock - Currency: EUR

9.05  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALMKS. ALMKS was compared to 63 industry peers in the Media industry. ALMKS has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ALMKS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALMKS has reported negative net income.
In the past year ALMKS had a positive cash flow from operations.
ALMKS had negative earnings in 4 of the past 5 years.
Of the past 5 years ALMKS 4 years had a positive operating cash flow.
ALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

ALMKS's Return On Assets of -1.00% is on the low side compared to the rest of the industry. ALMKS is outperformed by 71.43% of its industry peers.
With a Return On Equity value of -6.68%, ALMKS is not doing good in the industry: 69.84% of the companies in the same industry are doing better.
With a decent Return On Invested Capital value of 7.61%, ALMKS is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -1%
ROE -6.68%
ROIC 7.61%
ROA(3y)-2.48%
ROA(5y)-1.44%
ROE(3y)-22.79%
ROE(5y)-9.81%
ROIC(3y)N/A
ROIC(5y)N/A
ALMKS.PA Yearly ROA, ROE, ROICALMKS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

With a Operating Margin value of 1.87%, ALMKS is not doing good in the industry: 65.08% of the companies in the same industry are doing better.
ALMKS's Operating Margin has declined in the last couple of years.
The Gross Margin of ALMKS (20.49%) is worse than 82.54% of its industry peers.
ALMKS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.87%
PM (TTM) N/A
GM 20.49%
OM growth 3YN/A
OM growth 5Y-6.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.38%
GM growth 5Y-5.28%
ALMKS.PA Yearly Profit, Operating, Gross MarginsALMKS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALMKS is creating some value.
ALMKS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALMKS has been increased compared to 5 years ago.
Compared to 1 year ago, ALMKS has an improved debt to assets ratio.
ALMKS.PA Yearly Shares OutstandingALMKS.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALMKS.PA Yearly Total Debt VS Total AssetsALMKS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ALMKS has an Altman-Z score of 1.75. This is a bad value and indicates that ALMKS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALMKS (1.75) is better than 60.32% of its industry peers.
The Debt to FCF ratio of ALMKS is 1126.96, which is on the high side as it means it would take ALMKS, 1126.96 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1126.96, ALMKS is doing worse than 68.25% of the companies in the same industry.
A Debt/Equity ratio of 0.47 indicates that ALMKS is not too dependend on debt financing.
ALMKS has a Debt to Equity ratio of 0.47. This is in the better half of the industry: ALMKS outperforms 61.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1126.96
Altman-Z 1.75
ROIC/WACC1.11
WACC6.84%
ALMKS.PA Yearly LT Debt VS Equity VS FCFALMKS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

ALMKS has a Current Ratio of 0.75. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
ALMKS has a worse Current ratio (0.75) than 76.19% of its industry peers.
ALMKS has a Quick Ratio of 0.75. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
ALMKS has a worse Quick ratio (0.73) than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.73
ALMKS.PA Yearly Current Assets VS Current LiabilitesALMKS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

ALMKS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.02%, which is quite impressive.
Looking at the last year, ALMKS shows a quite strong growth in Revenue. The Revenue has grown by 16.03% in the last year.
The Revenue has been growing by 51.21% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)63.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-319.11%
Revenue 1Y (TTM)16.03%
Revenue growth 3Y35.32%
Revenue growth 5Y51.21%
Sales Q2Q%21.07%

3.2 Future

The Earnings Per Share is expected to grow by 64.22% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALMKS will show a quite strong growth in Revenue. The Revenue will grow by 18.17% on average per year.
EPS Next Y106.06%
EPS Next 2Y64.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.09%
Revenue Next 2Y20.54%
Revenue Next 3Y18.17%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALMKS.PA Yearly Revenue VS EstimatesALMKS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
ALMKS.PA Yearly EPS VS EstimatesALMKS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMKS. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 13.05, ALMKS is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALMKS is on the same level as its industry peers.
ALMKS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.04.
Industry RankSector Rank
PE N/A
Fwd PE 13.05
ALMKS.PA Price Earnings VS Forward Price EarningsALMKS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALMKS is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
68.25% of the companies in the same industry are cheaper than ALMKS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1618.9
EV/EBITDA 9.75
ALMKS.PA Per share dataALMKS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

ALMKS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALMKS's earnings are expected to grow with 64.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.22%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALMKS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAKING SCIENCE GROUP SA

EPA:ALMKS (8/8/2025, 7:00:00 PM)

9.05

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.56%
Inst Owner ChangeN/A
Ins Owners63.56%
Ins Owner ChangeN/A
Market Cap81.27M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)12.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.05
P/S 0.3
P/FCF 1618.9
P/OCF 249.37
P/B 3.16
P/tB N/A
EV/EBITDA 9.75
EPS(TTM)-0.19
EYN/A
EPS(NY)0.69
Fwd EY7.66%
FCF(TTM)0.01
FCFY0.06%
OCF(TTM)0.04
OCFY0.4%
SpS30.46
BVpS2.87
TBVpS-4.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1%
ROE -6.68%
ROCE 10.35%
ROIC 7.61%
ROICexc 13.76%
ROICexgc N/A
OM 1.87%
PM (TTM) N/A
GM 20.49%
FCFM 0.02%
ROA(3y)-2.48%
ROA(5y)-1.44%
ROE(3y)-22.79%
ROE(5y)-9.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-6.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.38%
GM growth 5Y-5.28%
F-Score6
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1126.96
Debt/EBITDA 1.05
Cap/Depr 4.23%
Cap/Sales 0.1%
Interest Coverage 1.14
Cash Conversion 2.8%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.73
Altman-Z 1.75
F-Score6
WACC6.84%
ROIC/WACC1.11
Cap/Depr(3y)13.72%
Cap/Depr(5y)311.76%
Cap/Sales(3y)0.4%
Cap/Sales(5y)7.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-319.11%
EPS Next Y106.06%
EPS Next 2Y64.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.03%
Revenue growth 3Y35.32%
Revenue growth 5Y51.21%
Sales Q2Q%21.07%
Revenue Next Year24.09%
Revenue Next 2Y20.54%
Revenue Next 3Y18.17%
Revenue Next 5YN/A
EBIT growth 1Y279.3%
EBIT growth 3YN/A
EBIT growth 5Y41.57%
EBIT Next Year207.02%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y103.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y177.63%
OCF growth 3Y-64.38%
OCF growth 5YN/A